Ruth Brauer joined the Section of Women’s Mental Health as a Postdoctoral Researcher in May 2015. She has a BSc in Mental Health and Health Promotion and MPhil in Clinical Epidemiology from Maastricht University. Ruth won a scholarship at the London School of Hygiene and Tropical Medicine (LSHTM) to read her PhD in Pharmacoepidemiology. The results of which were published as papers in in the European Heart Journal and Pharmacoepidemiology and Drug Safety.
As a post-doc at LSHTM she completed a cohort study on the protective effect of glitazones on the risk of Parkinson's disease in individuals with diabetes. The results of this study were published in PLoS Medicine.
Ruth is currently working on the pilot trial of a Patient Decision Aid for Antidepressant Use in Pregnancy. Her main research interest is how best to quantify the individual patient risk of drug adverse effects. She is currently involved in research using UK electronic health records and data linkages to study the protective effect of minocycline on mental health and the effect of lithium on neonatal morbidity.